NAD+
NAD+ helps cells carry out chemical reactions. It is a research substance, not a peptide.
Whole vial: 500 mg Vial math ↓
Why people look it up
NAD+ is essential to cell energy reactions, so wellness discussions often connect it to energy, aging, and mental clarity. NAD+ itself is not a peptide.
Cell-energy chemistryMECHANISTIC / LAB EVIDENCE
NAD+ participates in cellular reactions; a biological role is not evidence that added NAD+ improves symptoms. Read source ↗
Human NAD+ handling after infusionLIMITED HUMAN EVIDENCE
A pilot measured blood and urine metabolites during an infusion, not clinical benefit. Read source ↗
Energy, focus, or anti-aging benefitINSUFFICIENT EVIDENCE
The infusion pilot was not designed to establish these outcomes. Read source ↗
The labels show the evidence for each claim. Open a row for its source.
Dosage at a glance
Dosage source summary
- Lower example
- 25 mg
- Middle example
- 50 mg
- Higher example
- 100 mg
- How often
- The account describes daily use first, then three times weekly.
- Time on / time off
- No established cycle or break pattern.
- Route
- Injection; subcutaneous versus intramuscular not stated.
All three amounts appear in one account. The exact amount-to-frequency pairing is unclear; this is not a matched dosing plan.
These source amounts do not establish a safe human dose for a research vial.
Sources & individual reports
All three amounts appear in one account. The exact amount-to-frequency pairing is unclear; this is not a matched dosing plan. Source check: 2026-10-18.
Source coverage: 3 reviewed public accounts. Separate examples, not a representative sample.
Report 1 ↗First-person account
- Amount reported
- about 50 mg each time (poster stated 25 U from a 500 mg / 2.5 mL vial)
- How often reported
- twice weekly
- Reported duration / cycle
- duration not stated
- Route (how it was taken)
- subcutaneous, stated in reply
What the account says: Poster described burning and redness and reported crystallization. Product identity and concentration were self-reported; no clinical outcome was established.
Product match & source details
Product match: 500 mg dry NAD+ vial described; not verified as this seller’s product.
r/Peptidesource firsthand comment · Posted: 2024-02-27 · Reviewed: 2026-10-03.
Report 2 ↗First-person account
- Amount reported
- 25 mg, then 50 mg, then 100 mg each time
- How often reported
- daily at first; later three times weekly
- Reported duration / cycle
- second 500 mg vial by time of comment
- Route (how it was taken)
- injection; subcutaneous versus intramuscular not stated
What the account says: Poster reported no noticeable energy benefit despite changing amounts. Oral experience mentioned in the same comment belonged to another person and was excluded.
Product match & source details
Product match: A 500 mg injection vial was described; not verified as this seller’s formulation.
r/Peptidesource firsthand comment · Posted: date not independently verified · Reviewed: 2026-10-03.
Report 3 ↗First-person account
- Amount reported
- 30–50 mg each time
- How often reported
- daily
- Reported duration / cycle
- duration not stated
- Route (how it was taken)
- not stated
What the account says: A commenter reported their own amount from a 1000 mg vial; the thread opener was only asking about a plan and was not counted as use.
Product match & source details
Product match: 1000 mg NAD+ vial, not the same vial size as this listing.
r/PeptideDiscussion firsthand comment · Posted: date not independently verified · Reviewed: 2026-10-03.
How much agreement is there? Three checked dry-vial or injected-product accounts vary markedly in amount and frequency. They do not establish a typical or safe range, and one reported no perceived benefit.
Public sources last reviewed: 2026-10-03. Product identity and reported results were not independently verified. Source method →
Evidence, sources & vial math
What the research actually showsHuman studies, evidence limits and mechanisms
What has actually been studied?
A small human infusion pilot tracked NAD+ metabolites in blood and urine, not whether participants felt better or lived longer. Route and formulation matter.
Evidence limits: NAD+ is not a peptide. Results from a different formulation or route cannot establish a regimen or outcome for this vial.
Product status: Research-vial listings are not FDA-approved medicines. Approved-use labels on this page refer only to the named finished prescription product.
Human research
NAD+ infusion and blood/urine metabolite pilot 2019
What was found: Plasma NAD+ and several metabolites rose later in the infusion; this was a metabolism observation, not a symptom or longevity outcome.
Main limit: Only 11 men, brief follow-up, no clinical benefit outcome, and a prepared IV solution unlike this dry research vial.
Study setup and amounts
- Who
- Healthy men ages 30–55
- Number of participants
- 11 total; 8 NAD+ infusion, 3 saline controls
- Study design
- Small randomized saline-controlled metabolism pilot
- Route
- Intravenous infusion
- Amount studied
- 750 mg NAD+ infused over six hours in the active group
- Frequency
- One six-hour infusion
- Duration
- Blood and urine followed for eight hours from infusion start
- Outcome measured
- Plasma and urine NAD+ and related metabolites
Study and prescription-product amounts describe those sources. They do not select an amount for an online research vial.
How researchers think it might work
NAD+ is a helper molecule cells use to move energy through chemical reactions. Giving extra NAD+ is a separate question from its normal job inside cells.
Show scientific explanation
An 11-person randomized infusion pilot measured how intravenously administered NAD+ and its metabolites appeared in blood and urine over eight hours. It measured handling, not a clinical energy or aging benefit. Read supporting source ↗
Vial & syringe mathTurn the vial total and liquid volume into concentration and syringe units
Vial & syringe math
Change the vial total and final liquid volume to see what each U-100 syringe mark represents.
The starting 1 mL is a math example. Enter your final mixed volume to update the numbers.
100 U-100 syringe units = 1 mL. These results assume the labeled amount is evenly mixed through the final liquid volume.
Continue in the calculator →About this listingResearch-use-only status, seller names and additional background
A research material is not intended for human use. Its name or lab report does not establish suitability for a person. What research use only means →
Compiled by PeptideWhy · Scientific sources last checked 2026-10-03 · Editorial policy · Corrections